Home » Newsletters » BioWorld

BioWorld

Jan. 10, 2001

View Archived Issues

InterMune Buying Alza Drug For $9M, Boosting Sales Force

SangStat Raises $12.5M Privately, Plans To Be Profitable This Year

Raven Biotech Brings In $20.6M To Develop Antibody Therapeutics

BIO Names Cohen To Head New Health Policy Position

Acorda Plans To Move Programs Along Following $33.7M Round

Other News To Note

Atrix Licenses Leuprogel Rights To Sanofi In Up-To-$60M Alliance

IntraBiotics Paying Diversa $20M In Antibacterial Deal

Adverse Events In Oxygent Patients Stops Alliance Study, Drops Stock

SADS, A Pro-Cell-Suicide Protein, Down-Regulated In Colon Cancer Tissue, Daiichi Scientists Report